Goldman Sachs analyst: Non-farm payrolls data is just a side dish, the main course is tariffs
‘Today's better-than-expected jobs report helped ease market concerns about immediate weakness in the U.S. labour market,’ said Lindsay Rosner, Head of Diversified Fixed Income Investments at Goldman Sachs Asset Management, ’However, this data is just a side dish right now, and the market is focused on the main course: the tariff issue.’
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like


BTC market cap briefly dropped out of the top 15 global assets

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit
An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.
